Xingren Doctor

What Xingren Doctor does

Xingren Doctor (未来医生), also operating under the MedLinker brand, is a Beijing-headquartered digital health company founded in 2014 that operates a direct-to-consumer telemedicine platform connecting individual patients with senior specialists from Grade A tertiary hospitals across China. The company serves patients through the 未来医生 (Future Doctor) mobile application (iOS/Android), a WeChat mini-program, and a web platform at medlinker.com, with a separately listed expert roster that includes senior physicians from Peking Union Medical College Hospital, Peking University People's Hospital, Beijing Jishuitan Hospital, PLA General Hospital, Sichuan University West China Hospital, and other leading institutions. Its core product surface covers 26 clinical secondary disciplines, 109 subspecialties, and over 30,000 disease types, supported by an in-house AI decision-support system called MedGPT that retrieves from 100,000+ global medical guidelines, 8 million evidence units, 650+ algorithmic calculation units, 2,000+ ICD disease types, and an experience database co-built with 120+ tertiary hospital experts — with all AI-generated recommendations explicitly reviewed by licensed clinicians before delivery to patients.

The company's monetization is built on a fee-for-service consultation model — patients pay for expedited access to top-tier specialists through the app, mini-program, and web platforms, supplemented by prescription delivery in selected regions within 30 minutes. Beyond the patient-facing product, Xingren Doctor has expanded into adjacent B2B and B2B2C surfaces: an AI企业应用平台 (AI Enterprise Application Platform), an AI医疗应用平台 (AI Medical Application Platform) for medical institutions, a 保险行业解决方案 (Insurance Industry Solutions) offering, and a doctor-side AI studio called DoctorWorks.AI (doctorwork.ai), indicating a deliberate diversification of the revenue base beyond consumer consultations.

The company is privately held and has raised approximately $37 million across two disclosed rounds — a $4.95M round in 2014 led by HSG with Luminous Ventures (formerly Lightspeed China Partners), and a $32M round in July 2015 led by FountainVest Partners with HSG and Luminous Ventures participating. It operates a workforce of 501–1,000 employees, holds an Internet Drug Information Service License issued by Sichuan provincial authorities, and is led by CEO and founder Martin Shen. Geographic operations are concentrated in China with no disclosed international footprint.

Name

Xingren Doctor

Legal name

北京智医方程科技有限公司

Website

https://xingren.com

Company type

Private

Founded year

2014

Operating status

Operating

Headcount range

501–1,000 employees

Short description

Xingren Doctor (未来医生) is a Beijing-based telemedicine company founded in 2014 that connects Chinese patients with senior specialists from top-tier (三甲) hospitals through its Future Doctor mobile app, WeChat mini-program, and the MedGPT AI clinical decision-support system.

Ownership category

akta.pro rank

Product category

Telemedicine

NAICS

Offices of Physicians (62111)

SIC

Services-Offices & Clinics Of Doctors Of Medicine (8011), Services-Health Services (8000)

akta.pro primary industry

Virtual Specialty Care Platforms (tele-stroke, tele-ICU, tele-derm, tele-cardiology) (HLALABAD)

akta.pro secondary industries

Virtual Second Opinion & Care Navigation Platforms (HLALAAAF), Primary Care & General Medicine Virtual Care (HLALAAAA)

Keywords

• Telemedicine services
• Online medical consultation
• AI medical diagnosis
• Specialist doctor access
• Digital healthcare platform

Headquarters

HQ city

Shanghai

HQ country

China

HQ region

Asia

Offices1 record

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Technology or R&D, Operations, Marketing or Sales, Others

Revenue model

1. Medical Consultation Services: Fee-for-service model where patients pay for expedited access to expert medical consultations from top-tier hospital specialists via the mobile platform. Services include instant specialist consultations and AI-assisted diagnosis review by real physicians.

Go-to-market motion1 record

Distribution channels4 records

Marketing channels4 records

Core offering

Xingren Doctor (未来医生 / Future Doctor) operates a digital healthcare platform that connects individual patients with top-tier Chinese hospital specialists via a mobile app, WeChat mini-program, and web interface. The platform provides rapid access to expert medical consultations from Grade A tertiary (三甲) hospitals, augmented by the proprietary MedGPT AI diagnostic decision-support system. All AI-generated recommendations are verified by licensed clinical physicians before delivery to patients, and additional offerings include enterprise AI platforms and insurance industry solutions.

Product overview

Xingren Doctor operates as a multi-platform healthcare ecosystem centered on its core telemedicine app. The primary offering is the 未来医生 (Future Doctor) app, which provides two integrated consultation services: 名医极速问诊 (Expert Fast Consultation) for rapid access to leading specialists, and AI-assisted diagnosis powered by MedGPT. The platform spans enterprise offerings (AI企业应用平台 and AI医疗应用平台) and industry-specific solutions (保险行业解决方案), with DoctorWorks.AI serving as the underlying AI studio. The architecture combines a consumer-facing patient app, a doctor-side portal (DoctorWorks.AI), and enterprise AI platforms for institutional and insurance sector clients.

Differentiator

Problem solved

Functional benefit

Brands

• MedGPT: AI medical application platform for diagnostic and consultation support
• DoctorWorks.AI
• AI企业应用平台
• AI医疗应用平台
• 保险行业解决方案

Products and services

• 未来医生 (Future Doctor) Mobile Application

Quantifiable outcome

• 95%+ disease coverage through 26 secondary disciplines and 109 subspecialties
• +1 more outcomes

Named customers1 record

Segments1 record

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability4 records

Feature3 records

Scale indicators3 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Ping An Healthcare and Technology (Ping An Good Doctor): Ping An Good Doctor is China's largest D2C telehealth platform, offering AI-augmented consultations, in-house medical teams, and integration with the Ping An insurance ecosystem. It competes directly with Xingren Doctor in mobile specialist consultations and second-opinion services, with materially stronger funding and brand recognition.
• JD Health: JD Health operates one of China's leading online healthcare platforms combining telehealth consultations with pharmaceutical e-commerce. It competes head-to-head with Xingren Doctor in D2C specialist consultations and leverages JD.com's logistics network for prescription delivery — analogous to Xingren Doctor's 30-minute prescription delivery feature.
• Alibaba Health (AliHealth): Alibaba Health combines telehealth, pharmaceutical e-commerce, and traceability services through Tmall and Alipay distribution. It is a direct competitor to Xingren Doctor in D2C consultations and similarly targets access to specialists from leading Chinese hospitals, with superior consumer traffic from the Alibaba ecosystem.
• We Doctor (WeDoctor / 微医): We Doctor (backed by Tencent) is a leading Chinese digital health platform offering appointments, consultations, and an AI-enabled family doctor service. It competes directly with Xingren Doctor in D2C specialist access and shares a similar model of connecting patients to top-tier hospital physicians across China.
• Chunyu Doctor (春雨医生): Chunyu Doctor is one of China's earliest D2C telehealth apps, combining AI-assisted triage with text-based consultations from licensed physicians. It is a direct competitor to Xingren Doctor in the consumer-facing mobile consultation category, though with a less specialist-heavy model.
• Hao Daifu Online (好大夫在线): Hao Daifu Online is a long-established Chinese platform focused on doctor discovery, appointment booking, and patient-to-specialist consultations from leading hospitals. It directly overlaps with Xingren Doctor's core value proposition of connecting patients to top 三甲 specialists across multiple disciplines.

Emerging players

• DXY (Dingxiang Yuan / 丁香园): DXY is a leading Chinese physician community and consumer health content platform that has expanded into telehealth consultations and digital pharma services. It is comparable to Xingren Doctor in the AI-augmented consultation space, with a stronger provider-side brand and broader health content ecosystem.
• Babylon Health: Babylon Health built an AI-driven symptom triage and virtual consultation platform serving both consumers and enterprise payers. While UK/US-focused, it is comparable to Xingren Doctor in deploying AI-powered clinical decision support on top of a D2C telehealth front-end with B2B expansion ambitions.

Broad incumbents

• Teladoc Health: Teladoc Health is the global incumbent in D2C telehealth and second-opinion services with deep multi-specialty coverage and enterprise payer contracts. While geographically distinct from Xingren Doctor, it offers a comparable business model of AI-augmented remote specialist access and B2B licensing pathways.
• Tencent Health: Tencent Health (embedded within WeChat and backed by the We Doctor investment) operates as a broad digital health incumbent with strong distribution through the WeChat super-app — the same channel Xingren Doctor relies on. It is comparable as a WeChat-native telehealth player with enterprise-grade healthcare AI ambitions.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/xingren-trusted-doctors

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds2 records

Investors3 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Xingren Doctor